Skip to content

IDEAYA Biosciences, Inc.

IDYA

CIK 0001676725

← back to feed
Revenue (TTM)
$214.39M
+3,024.4% YoY Q1 May 2026
Net Income (TTM)
−$128.96M
+58.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.48
+61.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-80.8%
Q1 May 2026
Net Margin
-60.2%
Q1 May 2026
Free Cash Flow (TTM)
−$210.83M
Q1 May 2026
Cash
$157.52M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
87.86M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings